Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma

F Qi, W Tang - BioScience Trends, 2021 - jstage.jst.go.jp
Traditional Chinese medicine (TCM) is a valuable form of medicine with a long history in
China. It has played a significant role in the control and prevention of infectious diseases …

The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic

M Majchrzak, M Poręba - Pharmacological Reports, 2022 - Springer
The unprecedented pandemic of SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2), which leads to COVID-19, is threatening global health. Over the last 2 years …

Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis

L Szarpak, KJ Filipiak, A Gasecka, W Gawel… - Cardiology …, 2022 - journals.viamedica.pl
Background: Vitamin D is a likely candidate for treatment as its immune modulating
characteristics have effects on coronavirus disease 2019 (COVID-19) patients. It was sought …

Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 …

E Hosseini, HR Kohan-Ghadr, M Bazrafkan… - Journal of assisted …, 2023 - Springer
The respiratory system was primarily considered the only organ affected by Coronavirus
disease 2019 (COVID-19). As the pandemic continues, there is an increasing concern from …

Exploration of the mechanism of Lianhua Qingwen in treating influenza virus pneumonia and new coronavirus pneumonia with the concept of “different diseases with …

H Su, G Wu, L Zhan, F Xu, H Qian… - Evidence‐Based …, 2022 - Wiley Online Library
The 31 main components of Lianhua Qingwen (LHQW) were obtained through a literature
and database search; the components included glycyrrhizic acid, emodin, chlorogenic acid …

Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

Y Ventura-Carmenate, FM Alkaabi… - Translational Medicine …, 2021 - Springer
Abstract Background The novel SARS-CoV-2 has caused the coronavirus disease 2019
(COVID-19) pandemic. Currently, with insufficient worldwide vaccination rates, identifying …

[HTML][HTML] Immune profiling of COVID-19: preliminary findings and implications for the pandemic

HT Maecker - Journal for immunotherapy of cancer, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 infection can have widely diverse clinical outcomes, from asymptomatic
infection to death, with many possible clinical symptoms and syndromes. It is thus essential …

[HTML][HTML] Presentation and outcomes of chronic kidney disease patients with COVID-19

CG Branco, I Duarte, J Gameiro, C Costa… - Brazilian Journal of …, 2021 - SciELO Brasil
Introduction: COVID-19 is currently a global health issue and an important cause of mortality.
Chronic kidney disease (CKD) is one of the risk factors for infection, morbidity and mortality …

Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia

L Masotti, E Grifoni, G Pelagalli, E Cioni… - International …, 2022 - Elsevier
Introduction and aim Interleukin-6 to lymphocyte (IL-6/Lym) ratio has been identified as a
potential prognostic tool in patients with SARS-CoV2 related pneumonia. The aim of our …

Antibody levels to SARS‐CoV‐2 spike protein in mothers and children from delivery to six months later

M Martin‐Vicente, I Carrasco, MJ Muñoz‐Gomez… - Birth, 2023 - Wiley Online Library
Introduction Pregnant women are vulnerable to severe acute respiratory syndrome
coronavirus (SARS‐CoV‐2) infection. Neutralizing antibodies against the SARS‐CoV‐2 …